Nkarta (NKTX) Cash from Operations (2019 - 2026)
Nkarta's (NKTX) quarterly Cash from Operations came in at 28199000.0 in Q1 2026, up 4.77% year-on-year from 26914707.11 in Q1 2025, and down 30.27% quarter-over-quarter from 21647000.0 in Q4 2025.
Nkarta (NKTX) Cash from Operations (2019 - 2026) Analysis & Trends
Nkarta's Cash from Operations history runs 8 years deep, the most recent figure standing at 28199000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations rose 4.77% year-over-year to 28199000.0 in Q1 2026; TTM through Mar 2026 was 87286000.0, a 13.41% increase from a year earlier, with the FY2025 full-year figure at 88699000.0, up 11.03% from the prior year.
- Cash from Operations eased to 28199000.0 in Q1 2026 per NKTX's latest filing, from 21647000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 7331000.0 in Q4 2022 and bottomed at 29612000.0 in Q1 2025.
- The 5-year median for Cash from Operations is 21647000.0 (2025), against an average of 21162000.0.
- Across the five-year window, Cash from Operations surged 58.28% in 2022 and tumbled 218.56% in 2023, its largest moves.
- Year by year, Cash from Operations stood at 7331000.0 in 2022, then tumbled by 218.56% to 23354000.0 in 2023, then fell by 5.98% to 24751000.0 in 2024, then rose by 12.54% to 21647000.0 in 2025, then plunged by 30.27% to 28199000.0 in 2026.
- Per Business Quant, the three latest NKTX Cash from Operations figures stand at 28199000.0 (Q1 2026), 21647000.0 (Q4 2025), and 18687000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | -28.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.20 Mn |
| Mar 31, 2026 | -28.20 Mn |
| Dec 31, 2025 | -21.65 Mn |
| Dec 31, 2025 | -21.65 Mn |
| Sep 30, 2025 | -18.69 Mn |
| Sep 30, 2025 | -18.69 Mn |
| Jun 30, 2025 | -18.75 Mn |
| Jun 30, 2025 | -18.75 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Dec 31, 2024 | -24.75 Mn |
| Dec 31, 2024 | -24.75 Mn |
| Sep 30, 2024 | -24.55 Mn |
| Sep 30, 2024 | -24.55 Mn |
| Jun 30, 2024 | -21.89 Mn |
| Jun 30, 2024 | -21.89 Mn |
| Mar 31, 2024 | -28.51 Mn |
| Mar 31, 2024 | -28.51 Mn |
| Dec 31, 2023 | -23.35 Mn |
| Dec 31, 2023 | -23.35 Mn |